Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
```
REGISTERED COMPANY NUMBER: 05879644 (England and Wales)
REGISTERED CHARITY NUMBER: 1119431
```
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
```
Report of the Trustees and
```
```
Audited Financial Statements
```
```
for the Year Ended 31 December 2023
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
```
Contents of the Financial Statements
for the Year Ended 31 December 2023
```
||**`Page`**|
|---|---|
|**`Report of the Trustees`**|`1 to 7`|
|**`Report of the Independent Auditors`**|`8 to 11`|
|**`Statement of Financial Activities`**|`12`|
|**`Balance Sheet`**|`13`|
|**`Cash Flow Statement`**|`14`|
|**`Notes to the Cash Flow Statement`**|`15`|
|**`Notes to the Financial Statements`**|`16 to 27`|
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Report of the Trustees`**
## **`for the Year Ended 31 December 2023`**
```
Thetrusteeswhoarealsodirectorsof thecharityforthepurposesof theCompaniesAct2006,present their
reportwiththefinancialstatementsofthecharityfortheyearended31December2023.Thetrustees have
adoptedtheprovisionsofAccountingandReportingbyCharities:StatementofRecommended Practice
applicabletocharitiespreparingtheiraccountsinaccordancewiththeFinancialReporting Standard
applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
```
## **`OBJECTIVES AND ACTIVITIES`**
## **`Purposes and Aims`**
```
The Society'spurpose,as set out in the objectin the charitablecompany'smemorandumof association,is the
advancement of neurosurgery for the public benefit and the benefit of the community generally.
```
```
Society'spurposeisthestudyandadvancementofneurosurgery.TheSocietyaimstoadvance expertise,
knowledgeand trainingamongsurgeons,othermedicalpractitionersand all professionalsallied or concerned
with general public health generally having a qualification recognised by the National Health Service.
```
```
The Society thereby aims to relieve the sickness of persons suffering from surgical neurological disorders.
```
```
TheSocietypromotestheconductofresearch,tuition,mentoring,adviceandassistancegenerallyfor the
relief of sickness of persons suffering from neurological disorders.
```
```
The Societypromoteseducationand disseminationof knowledgeamongstthe communityby associating with
voluntary and other organisations and individuals with particular skills.
```
```
Fundingresources:Thesociety'sprincipalregularsourceofincomeisthesubscriptionfromits members.
Voluntarygiftsanddonationsincomearereceivedoccasionally.Hospitaltrustssupportthe National
NeurosurgeryAuditProgram.Fundsarecollectedbythecharityanddisbursedfromit.SBNSholds both
restricted and unrestricted funds, as mentioned below.
```
```
Page 1
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
```
Report of the Trustees
for the Year Ended 31 December 2023
```
## **`OBJECTIVES AND ACTIVITIES`**
## **`Significant activities`**
## `Bursaries:`
```
TwotravelBursariesto Nepaleseneurosurgicaltraineeswereawardedlast year.The SBNS has reinstated ten
UK bursariesand thefivenon-Europeancountries'travelconservatorshipsupportbursariesfromthe current
year.
```
```
A newSBNSPresident'sBursaryhasbeenintroduced,alongwithdoublingtheamountofthebursary budget
to support UK trainees.
```
## `SBNS mentorship`
```
The SBNS council worked to develop a peer-to-peer mentorship program. It is now operational.
```
## `SBNS helpline`
```
Thecouncilispursuingtooffer'members-inneed'afreephonehelpservicetopromotementalhealth and
well-being at the workplace.
```
## `SBNS Global`
```
TheSBNSGlobal,withTheDianaandAlanKarterFund,hasdevelopedinternationalbursariesto sponsor
neurosurgeonsfromLowandmedium-incomecountriestovisittheUKandsupportlocaltraineesto visit
LMIC countries to gain experience.
```
```
Page 2
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Report of the Trustees`**
## **`for the Year Ended 31 December 2023`**
## **`STRATEGIC REPORT`**
## **`Achievement and performance`**
## **`Charitable activities`**
```
TheSocietyofBritishNeurologicalSurgeonsundertakesawiderangeofactivitiesthataffect the
neurosurgicalcommunityin general.The SBNS is involvedin research,standardsand deliveryof neurosurgery
carein theGB& IRE.TheSBNScharityis focusedonthewell-beingofitsmembers,equality& diversity, and
promotes a workplace free from bullying, with empowerment and equality in opportunity.
```
```
Namechangeballotresults:67%of the membersvotedto retainthe nameof 'Societyof British Neurological
Surgeons.'
```
```
The Society's constitution is being updated, to be discussed in the next AGM.
```
## `Membership Activities:`
## `SBNS council meeting and executive committee meetings .`
```
Fourmeetingswereheldthroughouttheyeartoformulate,reviewanddiscusspoliciesforneurosurgery in
the United Kingdom,the implicationsof governmentpolicyproposals,issues aroundtrainingand the financial
position of the society.
```
```
SBNSsubcommitteesdeliberatedonthetopicsofResearch,NationalAudit,GlobalNeurosurgery and
neurosurgical trainee matters.
```
```
SBNSconferenceswereheldinCork(spring)andLondon(autumn).SBNSmembersandother delegates
attendedthesescientificconferencestoexchangeknowledgeoncurrentneurosurgicalpractice.The SBNS
AGM was held during the autumn meeting.
```
## `SBNS Equality and Diversity`
```
TheEqualityandDiversitygroupexploredpracticesintheworkspacesandwithinthecharity.The findings
have been disseminated.The EDI reporthas now been submittedto the RCS and placedon the SBNS website.
ThereportwassharedwiththemembersduringtheSBNSconference.Focusgroupsarenowlooking at
dropout rates for training via the FSSA and the demographics.
```
## `Green surgery meeting`
```
TheSBNSrepresentativecontinuedtoengagewiththegreensurgeryinitiative.SBNSwishestobe a
stakeholderinthisaspirationalenterprisetoreduceitscarbonfootprintduringtheoperativeprocess by
making sustainable changes.
```
## `National Neurosurgical Audit Programme`
```
TheNationalNeurosurgicalAuditProgrammeproducedareportonunit-levelperformanceanda further
report on COVID recovery. These reports were shared with respective trusts.
```
## `Clinical Pathways/Guidelines`
```
TheSBNScouncildeliberatedonvariousclinicalpathwaysduringtheyear.Thefollowingareof special
mention:
```
```
-Suspected Cauda Equina Syndrome Pathway
```
```
Page 3
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Report of the Trustees`**
## **`for the Year Ended 31 December 2023`**
```
-Perioperative Management of Anticoagulation and Antiplatelets in Spinal and Cranial Neurosurgery
-NICE (Subarachnoid Haemorrhage Guidelines)
```
## `The SBNS Archivist`
```
The society appointed two members as Archivist in preparation for SBNS100.
```
## **`Financial review`**
## **`Principal funding sources`**
```
TheSociety'sprincipalregularsourceoffundsis thesubscriptionincomefromitsmembers.Other voluntary
giftanddonationincomeis receivedfrombothprivateandcommercialdonors.TheNNAPis now supported
by hospital trusts, donations from which are collected by the charity and disbursed from it.
```
## **`Investment policy and objectives`**
```
TheSocietyhasadoptedareserveandinvestmentpolicy.SBNSwillpursueanethicalinvestment policy
commensurate with its founding principle. The investment policy is attached.
```
## `INVESTMENT 2023`
```
SBNShasinvested£500,000in cashreserve(FD)withLloydsBank.Theinterestearnedis plannedto expand
SBNS charitable activities, benefitting the membership.
```
```
SBNShasinvesteda restricteddonation- 'TheDianaandAlanKarterFund'withAFHwealthmanagement as
an SBNS Global Neurosurgery fund for charitable activities related to neurosciences in LMIC countries.
```
## **`Reserves policy`**
```
TheSocietyseekstomaintainitsuncommittedreservestocoverthreemonthsofourfixed office
expendituresplusacontingencyreservefortheestimatedcostsofthefollowingyear'sacademic meetings
and commitments regarding charitable work, as mentioned above.
```
## **`STRUCTURE, GOVERNANCE AND MANAGEMENT`**
## **`Governing document`**
```
The Societyis a charitablecompanylimitedby guaranteeas defined by the CompaniesAct 2006, incorporated
on18July2006andregisteredasacharityon31May2007.ItsMemorandumestablishedthe Society's
objects and powers and is governed under its Articles of Association.
```
## **`Recruitment and appointment of new trustees`**
```
Forcharitylaw,theSociety'strusteesarethedirectorsofthecharitablecompanywhoarethe elected
Officersof theSociety,exceptfortheSecretaries.All officersarenominatedfromamongand electedby Full
Members of the Society and serve in office for two years
```
```
Page 4
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
```
Report of the Trustees
for the Year Ended 31 December 2023
```
## **`STRUCTURE, GOVERNANCE AND MANAGEMENT`**
## **`Organisational structure`**
```
TheSocietyhasa CouncilofManagementofelectedOfficers(whowiththeexceptionoftheSecretaries are
alsothe directorsof the companyand for purposesof charitylaw are the trusteesof the charity),ten elected
membersappointedby nominationand election,five membersex-officioas appointedby the relevant bodies
approved by the Council from time to time, and one lay member appointed by invitation.
```
```
The Directorsare responsiblefor the managementof the businessof the Society.The Councilmeets regularly
to develop and review the Society's strategic direction and policy.
```
## **`Wider network`**
```
InfurtheranceofitscharitableobjecttheSocietyhasdevelopedandmaintainsrelationshipswith other
bodiesengagedintheadvancementofexpertise,knowledgeandunderstandingofneurosurgeryby the
promotionandstudyofneurosurgery.TheWFNS,EANS,UEMS,BNTA,SACinNeurosurgery,and the
IntercollegiateExaminationBoardareallrepresentedontheCounciloftheSocietybyex-officio members.
The Societyis affiliatedto the WFNS,EANS,and UEMS,and throughits ProfessionalDevelopment, Standards
&EducationCommitteeislinkedwithotherorganisationsinvolvedintheadvancementof education,
knowledge and training of medical and allied professionals.
```
## **`REFERENCE AND ADMINISTRATIVE DETAILS Registered Company number`**
```
05879644 (England and Wales)
```
## **`Registered Charity number`**
```
1119431
```
## **`Registered office`**
```
7 Swallow Place
London
W1B 2AG
```
## **`Trustees`**
```
Mr N D Mendoza Consultant (resigned 1.2.2023)
Mr A J Jenkins Consultant (resigned 15.9.2023)
Mr P L Grundy Consultant (resigned 15.9.2023)
Mr P C Whitfield
Mr S Basu (appointed 1.2.2023)
Mr P J A Hutchinson (appointed 15.9.2023)
Mr C C Wigfield (appointed 15.9.2023)
```
## **`Senior Statutory Auditor`**
```
Andrew Millet BA MBA FCA
```
```
Page 5
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Report of the Trustees`**
```
for the Year Ended 31 December 2023
```
## **`REFERENCE AND ADMINISTRATIVE DETAILS`**
## **`Solicitors`**
```
Sherrards LLP
7 Swallow Place
London
W1B 2AG
```
## **`Auditors`**
```
Millet Accountants Ltd
Beyond Aldgate Tower
2 Leman Street
Aldgate, London E1 2FA
```
## **`STATEMENT OF TRUSTEES' RESPONSIBILITIES`**
```
Thetrustees(whoarealsothedirectorsofTheSocietyofBritishNeurologicalSurgeonsforthepurposes of
companylaw)areresponsibleforpreparingtheReportoftheTrusteesandthefinancialstatements in
accordancewithapplicablelawandUnitedKingdomAccountingStandards(UnitedKingdom Generally
Accepted Accounting Practice).
```
```
Companylawrequiresthetrusteestopreparefinancialstatementsforeachfinancialyearwhichgivea true
andfairviewofthestateofaffairsofthecharitablecompanyandoftheincomingresourcesand application
ofresources,includingtheincomeandexpenditure,ofthecharitablecompanyforthatperiod.In preparing
those financial statements, the trustees are required to
```
- `select suitable accounting policies and then apply them consistently;`
- `observe the methods and principles in the Charity SORP;`
- `make judgements and estimates that are reasonable and prudent;`
- `prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in business.`
```
Thetrusteesareresponsibleforkeepingproperaccountingrecordswhichdisclosewithreasonable accuracy
atanytimethefinancialpositionofthecharitablecompanyandtoenablethemtoensurethatthe financial
statementscomplywith the CompaniesAct 2006.They are also responsiblefor safeguardingthe assetsof the
charitablecompanyandhencefortakingreasonablestepsforthepreventionanddetectionoffraud and
other irregularities.
```
```
In so far as the trustees are aware:
```
- `there is no relevant audit information of which the charitable company's auditors are unaware; and`
- `the trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditors are aware of that information.`
```
Page 6
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Report of the Trustees`**
```
for the Year Ended 31 December 2023
```
`Report of the trustees, incorporating a strategic report, approved by order of the board of trustees, as the company directors, on ............................................. and signed on the board's behalf by:` 30 August 2024
```
...................................................................
```
```
Mr S Basu - Trustee
```
```
Page 7
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`Report of the Independent Auditors to the Members of The Society of British Neurological Surgeons`**
## **`Opinion`**
```
WehaveauditedthefinancialstatementsofTheSocietyOfBritishNeurologicalSurgeons(the 'charitable
company')fortheyearended31December2023whichcompriseStatementOfFinancialActivities, Balance
SheetandCashFlowStatementandnotestothefinancialstatements,includingasummaryof significant
accountingpolicies.The financialreportingframeworkthat has been appliedin their preparationis applicable
lawandUnitedKingdomAccountingStandards,includingFinancialReportingStandard102The Financial
ReportingStandardapplicableintheUKandRepublicofIreland(UnitedKingdomGenerally Accepted
Accounting Practice).
```
- `In our opinion the financial statements:`
- `give a true and fair view of the state of the charitable company's affairs as at 31 December 2023 and of its incoming resources and application of resources, including its income and expenditure, for the year then ended;`
- `have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and`
- `have been prepared in accordance with the requirements of the Companies Act 2006.`
## **`Basis for opinion`**
```
WeconductedourauditinaccordancewithInternationalStandardsonAuditing(UK)(ISAs(UK)) and
applicablelaw.Ourresponsibilitiesunderthosestandardsarefurtherdescribedinthe Auditors'
responsibilitiesfortheauditofthefinancialstatementssectionofourreport.Weareindependentof the
charitablecompanyin accordancewith the ethicalrequirementsthat are relevantto our audit of the financial
statementsintheUK,includingtheFRC'sEthicalStandard,andwehavefulfilledourother ethical
responsibilitiesin accordancewith these requirements.We believethat the audit evidencewe have obtained
is sufficient and appropriate to provide a basis for our opinion.
```
## **`Conclusions relating to going concern`**
```
Inauditingthefinancialstatements,wehaveconcludedthatthetrustees'useofthegoingconcernbasis of
accounting in the preparation of the financial statements is appropriate.
```
```
Basedontheworkwehaveperformed,wehavenotidentifiedanymaterialuncertaintiesrelatingto events
orconditionsthat,individuallyorcollectively,maycastsignificantdoubtonthecharitablecompany's ability
to continueas a goingconcernfor a periodof at leasttwelvemonthsfromwhen the financialstatements are
authorised for issue.
```
```
Our responsibilitiesand the responsibilitiesof the trusteeswith respectto goingconcernare describedin the
relevant sections of this report.
```
## **`Other matters`**
```
The previousyear was unauditedand as such our audit reportdoes not extendto the corresponding amounts
withintheStatementOfFinancialActivities,BalanceSheet,CashFlowStatementandnotestothe financial
statements.Whereappropriatewehavecarriedoutworkontheopeningbalancestoensurethatthey do
not contain material misstatements that would affect the current year's financial statements.
```
```
Page 8
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`Report of the Independent Auditors to the Members of The Society of British Neurological Surgeons`**
## **`Other information`**
```
Theotherinformationcomprisestheinformationincludedintheannualreportotherthanthe financial
statementsandourauditor'sreportthereon.Thetrusteesareresponsiblefortheother information
containedwithintheannualreport.Ouropiniononthefinancialstatementsdoesnotcoverthe other
informationand, exceptto the extentotherwiseexplicitlystatedin our report,we do not expressany form of
assuranceconclusionthereon.Ourresponsibilityistoreadtheotherinformationand,indoingso, consider
whethertheotherinformationismateriallyinconsistentwiththefinancialstatementsorour knowledge
obtainedinthecourseoftheauditorotherwiseappearstobemateriallymisstated.Ifweidentify such
materialinconsistenciesorapparentmaterialmisstatements,wearerequiredtodeterminewhether this
givesrisetoamaterialmisstatementinthefinancialstatementsthemselves.If,basedontheworkwe have
performed,weconcludethatthereisamaterialmisstatementofthisotherinformation,wearerequired to
report that fact.
```
```
We have nothing to report in this regard.
```
## **`Opinions on other matters prescribed by the Companies Act 2006`**
```
In our opinion, based on the work undertaken in the course of the audit:
```
- `the information given in the Report of the Trustees for the financial year for which the financial statements are prepared is consistent with the financial statements; and`
- `the Report of the Trustees has been prepared in accordance with applicable legal requirements.`
## **`Matters on which we are required to report by exception`**
```
Inthelightoftheknowledgeandunderstandingofthecharitablecompanyanditsenvironmentobtained in
the course of the audit, we have not identified material misstatements in the Report of the Trustees.
```
```
WehavenothingtoreportinrespectofthefollowingmattersinrelationtowhichtheCompaniesAct 2006
requires us to report to you if, in our opinion:
```
- `adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or`
- `the financial statements are not in agreement with the accounting records and returns; or`
- `certain disclosures of trustees' remuneration specified by law are not made; or`
- `we have not received all the information and explanations we require for our audit; or`
- `the trustees' were not entitled to prepare the financial statements in accordance with the small companies regime.`
## **`Responsibilities of trustees`**
```
As explainedmorefully in the Statementof Trustees'Responsibilities,the trustees(who are also the directors
ofthecharitablecompanyforthepurposesofcompanylaw)areresponsibleforthepreparationof the
financialstatementsand for being satisfiedthat they give a true and fair view, and for such internalcontrol as
thetrusteesdetermineisnecessarytoenablethepreparationoffinancialstatementsthatarefree from
material misstatement, whether due to fraud or error.
```
```
Inpreparingthefinancialstatements,thetrusteesareresponsibleforassessingthecharitable company's
abilitytocontinueasagoingconcern,disclosing,asapplicable,mattersrelatedtogoingconcernand using
the going concernbasis of accountingunless the trusteeseitherintend to liquidatethe charitablecompany or
to cease operations, or have no realistic alternative but to do so.
```
```
Page 9
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
```
Report of the Independent Auditors to the Members of
The Society of British Neurological
Surgeons
```
## **`Our responsibilities for the audit of the financial statements`**
```
Our objectivesare to obtain reasonableassuranceabout whetherthe financialstatementsas a whole are free
frommaterialmisstatement,whetherdue to fraud or error,and to issue an auditor'sreportthat includes our
opinion.Reasonableassuranceis a highlevelofassurance,butis nota guaranteethatan auditconducted in
accordancewith ISAs (UK)will alwaysdetecta materialmisstatementwhen it exists.Misstatementscan arise
fromfraudorerrorandareconsideredmaterialif,individuallyorin theaggregate,theycouldreasonably be
expected to influence the economic decisions of users taken on the basis of these financial statements.
```
```
The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:
```
## `As part of our planning process:`
```
- We enquiredof managementthe systemsand controlsthe charitablecompanyhas in place, the areas of the
financialstatementsthatare mostlysusceptibleto the risk of irregularitiesand fraud,and whetherthere was
anyknown,suspectedorallegedfraud.Thecompanydidnotinformusofanyknown,suspectedor alleged
fraud.
```
```
-Weobtainedanunderstandingofthelegalandregulatoryframeworksapplicabletothe charitable
company.Wedeterminedthatthefollowingweremostrelevant:FRS102,CompaniesAct2006,Charity Act
2011 and UK employment law.
```
```
- We consideredthe incentivesand opportunitiesthat exist in the charitablecompany,includingthe extent of
managementbias,whichpresentapotentialforirregularitiesandfraudtobeperpetuated,andtailored our
risk assessment accordingly.
```
```
-Usingourknowledgeofthecharitablecompany,togetherwiththediscussionsheldwiththe charitable
companyattheplanningstage,weformedaconclusionontheriskofmisstatementdueto irregularities
includingfraudandtailoredourproceduresaccordingtothisriskassessment.Thekeyprocedures we
undertook to detect irregularities including fraud during the course of the audit included:
```
```
-Identifyingandtestingjournalentriesandtheoverallaccountingrecords,inparticularthosethat were
significant and unusual.
```
```
-Reviewingthefinancialstatementdisclosuresanddeterminingwhetheraccountingpolicieshave been
appropriately applied.
```
```
-Reviewingandchallengingtheassumptionsandjudgementsusedbymanagementintheir significant
accountingestimates,inparticularinrelationtodoubtfuldebtprovision,stockprovisionand depreciation
methods.
```
```
-Assessingtheextentofcompliance,orlackof,withtherelevantlawsandregulations,inparticular those
that are central to the entities ability to continue in operation.
```
- `Testing key revenue lines, in particular cut-off, for evidence of management bias.`
- `Performing a physical verification of key assets.`
- `Obtaining third-party confirmation of material bank balances.`
- `Documenting and verifying all significant related party balances and transactions.`
- `Reviewing documentation such as the charitable company board minutes, correspondence with solicitors,`
- `for discussions of irregularities including fraud.`
```
Owingtotheinherentlimitationsofanaudit,thereisanunavoidableriskthatwemaynothave detected
somematerialmisstatementsinthefinancialstatementseventhoughwehaveproperlyplanned and
performedour audit in accordancewith auditingstandards.The primaryresponsibilityfor the prevention and
detection of irregularities and fraud rests with the directors.
```
```
Page 10
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`Report of the Independent Auditors to the Members of The Society of British Neurological Surgeons`**
```
A furtherdescriptionof our responsibilitiesfor the audit of the financialstatementsis locatedon the Financial
ReportingCouncil'swebsiteatwww.frc.org.uk/auditorsresponsibilities.Thisdescriptionformspartof our
Report of the Independent Auditors.
```
## **`Use of our report`**
```
Thisreportis madesolelytothecharitablecompany'smembers,asa body,in accordancewithChapter3 of
Part16oftheCompaniesAct2006.Ourauditworkhasbeenundertakensothatwemightstateto the
charitablecompany'smembersthosematterswe are requiredto stateto themin an auditors'reportand for
nootherpurpose.Tothefullestextentpermittedbylaw,wedonotacceptorassumeresponsibility to
anyoneotherthanthecharitablecompanyandthecharitablecompany'smembersasabody,forour audit
work, for this report, or for the opinions we have formed.
```
```
Andrew Millet BA MBA FCA (Senior Statutory Auditor)
```
31 August 2024
```
Date: .............................................
```
```
For and on behalf of Millet Accountants Ltd, Statutory Auditor
Beyond Aldgate Tower, 2 Leman Street, Aldgate, E1 8FA
```
```
Page 11
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Statement of Financial Activities for the Year Ended 31 December 2023`**
|`Unrestricted`
`fund`
`Notes`
`£`
**`INCOME AND ENDOWMENTS FROM`**
`Donations and legacies`
`3`
**`32,979`**
**`Charitable activities`**
`6`
`Educational and academic`
**`671,793`**
`Other trading activities`
`4`
**`41`**
`Investment income`
`5`
**`2,795`**
`Other income`
**`5,822`**
**`Total`**
**`713,430`**
**`EXPENDITURE ON`**
**`Charitable activities`**
`7`
`Bursaries and awards`
**`4,150`**
`Project support`
**`-`**
`Educational and academic`
**`674,693`**
`Governance costs`
**`16,410`**
`Other`
**`217,531`**
**`Total`**
**`912,784`**
**`NET INCOME/(EXPENDITURE)`**
**`(199,354)`**
**`RECONCILIATION OF FUNDS`**
`Total funds brought forward`
**`1,142,817`**
**`TOTAL FUNDS CARRIED FORWARD`**
**`943,463`**|`Restricted`
`funds`
`£`
**`1,250,000`**
**`-`**
**`-`**
**`1,493`**
**`-`**
**`1,251,493`**
**`-`**
**`1,000`**
**`-`**
**`2,000`**
**`-`**
**`3,000`**
**`1,248,493`**
**`67,230`**
**`1,315,723`**|**`2023`**
**`Total`**
**`funds`**
**`£`**
**`1,282,979`**
**`671,793`**
**`41`**
**`4,288`**
**`5,822`**
**`1,964,923`**
**`4,150`**
**`1,000`**
**`674,693`**
**`18,410`**
**`217,531`**
**`915,784`**
**`1,049,139`**
**`1,210,047`**
**`2,259,186`**|`2022`
`Total`
`funds`
`£`
`1,706`
`732,081`
`352`
`-`
`7,397`|
|---|---|---|---|
||||`741,536`|
||||`38,242`
`-`
`315,505`
`3,695`
`354,028`|
||||`711,470`|
||||`30,066`
`1,179,981`|
||||`1,210,047`|
```
The notes form part of these financial statements
```
```
Page 12
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Balance Sheet`**
## **`31 December 2023`**
|`Notes`
**`FIXED ASSETS`**
`Intangible assets`
`16`
`Investments`
`18`
**`CURRENT ASSETS`**
`Debtors`
`19`
`Cash at bank and in hand`
**`CREDITORS`**
`Amounts falling due within one year`
`20`
**`NET CURRENT ASSETS`**
**`TOTAL ASSETS LESS CURRENT LIABILITIES`**
**`NET ASSETS`**
**`FUNDS`**
`22`
`Unrestricted funds:`
`General fund`
`Restricted funds`
**`TOTAL FUNDS`**|**`2023`**
**`£`**
**`3,066`**
**`1,248,000`**
**`1,251,066`**
**`100,006`**
**`971,743`**
**`1,071,749`**
**`(63,629)`**
**`1,008,120`**
**`2,259,186`**
**`2,259,186`**
**`943,463`**
**`1,315,723`**
**`2,259,186`**|`2022`
`£`
`3,407`
`-`
`3,407`
`44,537`
`1,191,934`
`1,236,471`
`(29,831)`
`1,206,640`
`1,210,047`
`1,210,047`
`1,142,817`
`67,230`
`1,210,047`|
|---|---|---|
`The financial statements were approved by the Board of Trustees and authorised for issue on` 30 August 2024 `............................................. and were signed on its behalf by:`
```
.............................................
Mr S Basu - Trustee
```
```
The notes form part of these financial statements
```
```
Page 13
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Cash Flow Statement`**
## **`for the Year Ended 31 December 2023`**
|`Notes`
**`Cash flows from operating activities`**
`Cash generated from operations`
`1`
`Net cash provided by/(used in) operating activities`
**`Cash flows from investing activities`**
`Purchase of fixed asset investments`
`Interest received`
`Dividends received`
`Net cash (used in)/provided by investing activities`
**`Change in cash and cash equivalents in`**
**`the reporting period`**
**`Cash and cash equivalents at the`**
**`beginning of the reporting period`**
**`Cash and cash equivalents at the end of`**
**`the reporting period`**|**`2023`**
**`£`**
**`1,023,521`**
**`1,023,521`**
**`(1,248,000 )`**
**`2,795`**
**`1,493`**
**`(1,243,712 )`**
**`(220,191)`**
**`1,191,934`**
**`971,743`**|`2022`
`£`
`(10,672)`
`(10,672)`
`-`
`-`
`-`
`-`
`(10,672)`
`1,202,606`
`1,191,934`|
|---|---|---|
```
The notes form part of these financial statements
```
```
Page 14
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Notes to the Cash Flow Statement for the Year Ended 31 December 2023`**
|**`1.`**
**`RECONCILIATION OF NET INCOME TO NET CASH FLOW FROM OPERATING`**
**`Net income for the reporting period (as per the Statement of`**
**`Financial Activities)`**
**`Adjustments for:`**
`Depreciation charges`
`Interest received`
`Dividends received`
`Increase in debtors`
`Increase/(decrease) in creditors`
**`Net cash provided by/(used in) operations`**|**`ACTIVITIES`**
**`2023`**
**`£`**
**`1,049,139`**
**`341`**
**`(2,795)`**
**`(1,493)`**
**`(55,469)`**
**`33,798`**
**`1,023,521`**|`2022`
`£`
`30,066`
`379`
`-`
`-`
`(35,202)`
`(5,915)`
`(10,672)`|
|---|---|---|
```
2.ANALYSIS OF CHANGES IN NET FUNDS
```
|**`Net cash`**
`Cash at bank and in hand`
**`Total`**|`At 1/1/23`
`£`
**`1,191,934`**
**`1,191,934`**
**`1,191,934`**|`Cash flow`
**`£`**
**`(220,191)`**
**`(220,191)`**
**`(220,191)`**|**`At 31/12/23`**
**`£`**
**`971,743`**
**`971,743`**
**`971,743`**|
|---|---|---|---|
```
The notes form part of these financial statements
```
```
Page 15
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
```
Notes to the Financial Statements
for the Year Ended 31 December 2023
```
## **`1. CURRENCY`**
```
The Functional currency is Great British Pounds
```
## **`2. ACCOUNTING POLICIES`**
## **`Basis of preparing the financial statements`**
```
Thefinancialstatementsofthecharitablecompany,whichisapublicbenefitentityunderFRS 102,
havebeenpreparedinaccordancewiththeCharitiesSORP(FRS102)'AccountingandReporting by
Charities:StatementofRecommendedPracticeapplicabletocharitiespreparingtheiraccounts in
accordancewiththeFinancialReportingStandardapplicableintheUKandRepublicofIreland (FRS
102)(effective1January2019)',FinancialReportingStandard102'TheFinancialReporting Standard
applicableintheUKandRepublicofIreland'andtheCompaniesAct2006.Thefinancial statements
have been preparedunder the historicalcostconvention,with the exceptionof investmentswhich are
included at market value.
```
## **`Income`**
```
All incomeis recognisedin the Statementof FinancialActivitiesonce the charityhas entitlementto the
funds, it is probable that the income will be received and the amount can be measured reliably.
```
## **`Expenditure`**
```
Liabilitiesarerecognisedasexpenditureassoonasthereisalegalorconstructive obligation
committingthecharitytothatexpenditure,itisprobablethatatransferofeconomicbenefitswill be
requiredinsettlementandtheamountoftheobligationcanbemeasuredreliably.Expenditure is
accountedforonanaccrualsbasisandhasbeenclassifiedunderheadingsthataggregateall cost
relatedtothecategory.Wherecostscannotbedirectlyattributedtoparticularheadingsthey have
been allocated to activities on a basis consistent with the use of resources.
```
```
Grantsofferedsubjecttoconditionswhichhavenotbeenmetattheyearenddatearenotedas a
commitment but not accrued as expenditure.
```
## **`Allocation and apportionment of costs`**
```
CostsareallocatedbetweencategoriesofexpenditureoftheStatementofFinancial Activities
reflectingtheapplicationoftheresources.Costsrelatingtoa particularactivityareallocated directly,
others are apportioned on bases appropriate or on estimated usage.
```
## **`Intangible fixed assets - website`**
```
Depreciationisprovidedat10%perannumoncostinordertowriteofftheassetoverits estimated
useful life.
```
## **`Tangible fixed assets`**
```
Depreciationisprovidedatthefollowingannualratesinordertowriteoffeachassetover its
estimated useful life.
```
|`Fixtures and fittings`|`- 33% on cost`|
|---|---|
|`Computer equipment`|`- 33% on cost`|
```
continued...
```
```
Page 16
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Notes to the Financial Statements - continued for the Year Ended 31 December 2023`**
## **`2. ACCOUNTING POLICIES - continued`**
## **`Taxation`**
```
The Society is a registered charity and as such is exempt from taxation on its charitable activities.
```
## **`Financial instruments`**
```
TheCompanyonlyentersbasicfinancialinstrumenttransactionsthatresultintherecognition of
financialassetsandliabilitiesliketradeandotherdebtorsandcreditors,loansfrombanksand other
third parties, and investments in ordinary shares.
```
```
Financialassetsthataremeasuredatcostandamortizedcostareassessedattheendoof each
reportingperiod for objectiveevidenceof impairment.If objectiveevidenceof impairmentis found, an
impairment loss is recognised in the Profit and Loss Account.
```
```
Financialassetsand liabilitiesare offsetand the net amountreportedin the BalanceSheet when there
isanenforceablerighttosetofftherecognisedamountsandthereisanintentiontosettleona net
basis or to realise the asset and settle the liability simultaneously.
```
## **`3. DONATIONS AND LEGACIES`**
## **`4.`**
|`Donations`
`Legacies`
**`OTHER TRADING ACTIVITIES`**
`Insignia & merchandise`|**`2023`**
**`£`**
**`32,979`**
**`1,250,000`**
**`1,282,979`**
**`2023`**
**`£`**
**`41`**|`2022`
`£`
`1,706`
`-`|
|---|---|---|
|||`1,706`|
|||`2022`
`£`
`352`|
```
continued...
```
```
Page 17
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Notes to the Financial Statements - continued for the Year Ended 31 December 2023`**
|**`5.`**
**`INVESTMENT INCOME`**
`Other fixed asset invest`
`Fixed term deposit interest`
**`6.`**
**`INCOME FROM CHARITABLE ACTIVITIES`**
`Activity`
`Conference income`
`Educational and academic`
`NNAP`
`Educational and academic`
`Membership subscriptions`
`Educational and academic`|**`2023`**
**`£`**
**`1,493`**
**`2,795`**
**`4,288`**
**`2023`**
**`£`**
**`433,107`**
**`72,000`**
**`166,686`**
**`671,793`**|`2022`
`£`
`-`
`-`
`-`
`2022`
`£`
`365,406`
`198,000`
`168,675`|`2022`
`£`
`-`
`-`|
|---|---|---|---|
||||`-`|
|||`732,081`||
```
7.CHARITABLE ACTIVITIES COSTS
```
|`Grant`
`funding of`
`Direct`
`activities`
`Support`
`Costs (see`
`(see note`
`costs (see`
`note 8)`
`9)`
`note 10)`
`£`
`£`
`£`
`Bursaries and awards`
**`-`**
**`4,150`**
**`-`**
`Project support`
**`-`**
**`1,000`**
**`-`**
`Educational and academic`
**`521,416`**
**`-`**
**`153,277`**
`Governance costs`
**`-`**
**`-`**
**`18,410`**
**`521,416`**
**`5,150`**
**`171,687`**|`Totals`
`£`
**`4,150`**
**`1,000`**
**`674,693`**
**`18,410`**|
|---|---|
||**`698,253`**|
```
continued...
```
```
Page 18
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Notes to the Financial Statements - continued for the Year Ended 31 December 2023`**
|**`8.`**
**`DIRECT COSTS OF CHARITABLE ACTIVITIES`**
`Affiliations & memberships`
`Conferences`
**`9.`**
**`GRANTS PAYABLE`**
`Bursaries and awards`
`Project support`
**`10.`**
**`SUPPORT COSTS`**
`Other resources expended`
`Educational and academic`
`Governance costs`
`r`
`Other resources expended`
`Educational and academic`
`Governance costs`|**`2023`**
`2022`
**`£`**
`£`
**`63,613`**
`27,687`
**`457,803`**
`283,438`
**`521,416`**
`311,125`
**`2023`**
`2022`
**`£`**
`£`
**`4,150`**
`38,242`
**`1,000`**
`-`
**`5,150`**
`38,242`
`Information`
`Management`
`Finance`
`technology`
`£`
`£`
`£`
**`26,005`**
**`333`**
**`1,823`**
**`-`**
**`-`**
**`-`**
**`8,250`**
**`-`**
**`-`**
**`34,255`**
**`333`**
**`1,823`**
`Human`
`Governance`
`esources`
`Other`
`costs`
`Totals`
`£`
`£`
`£`
`£`
**`699`**
**`51,596`**
**`137,075`**
**`217,531`**
**`153,277`**
**`-`**
**`-`**
**`153,277`**
**`-`**
**`-`**
**`10,160`**
**`18,410`**
**`153,976`**
**`51,596`**
**`147,235`**
**`389,218`**|`2022`
`£`
`27,687`
`283,438`|`2022`
`£`
`27,687`
`283,438`|
|---|---|---|---|
|||`311,125`||
||||`2022`
`£`
`38,242`
`-`|
||||`38,242`|
|||**`1,823`**||
|||`Totals`
`£`
**`217,531`**
**`153,277`**
**`18,410`**||
|||**`389,218`**||
```
continued...
```
```
Page 19
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Notes to the Financial Statements - continued for the Year Ended 31 December 2023`**
## **`11. NET INCOME/(EXPENDITURE)`**
```
Net income/(expenditure) is stated after charging/(crediting):
```
||**`2023`**|`2022`|
|---|---|---|
||**`£`**|`£`|
|`Website amortisation`|**`341`**|`379`|
## **`12. TRUSTEES' REMUNERATION AND BENEFITS`**
```
Therewereno trustees'remunerationor otherbenefitsfor the yearended31 December2023nor for
the year ended 31 December 2022.
```
## **`Trustees' expenses`**
```
There were £2,447 of Trustee expenses paid in the year relating to travel costs. (2022 - Nil)
```
## **`13. STAFF COSTS`**
|`Wages and salaries`
`Other pension costs`
`The average monthly number of employees during the year was as follows:`
`Administrators`|**`2023`**
**`£`**
**`149,046`**
**`4,231`**
**`153,277`**
**`2023`**
**`2`**|`2022`
`£`
`166,929`
`4,380`|
|---|---|---|
|||`171,309`|
|||`2022`
`2`|
```
Thenumberofemployeeswhoseemployeebenefits(excludingemployerpensioncosts) exceeded
£60,000 was:
```
|`£60,001 - £70,000`
`£70,001 - £80,000`
`£80,001 - £90,000`|**`2023`**
**`1`**
**`1`**
**`-`**
**`2`**|`2022`
`-`
`1`
`1`|
|---|---|---|
|||`2`|
```
continued...
```
```
Page 20
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Notes to the Financial Statements - continued for the Year Ended 31 December 2023`**
|**`14.`**
**`COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES`**
`Unrestricted`
`fund`
`£`
**`INCOME AND ENDOWMENTS FROM`**
`Donations and legacies`
`500`
**`Charitable activities`**
`Educational and academic`
`732,081`
`Other trading activities`
`352`
`Other income`
`3,634`
**`Total`**
`736,567`
**`EXPENDITURE ON`**
**`Charitable activities`**
`Bursaries and awards`
`36,348`
`Educational and academic`
`315,505`
`Governance costs`
`3,695`
`Other`
`354,028`
**`Total`**
`709,576`
**`NET INCOME`**
`26,991`
**`RECONCILIATION OF FUNDS`**
`Total funds brought forward`
`1,115,826`
**`TOTAL FUNDS CARRIED FORWARD`**
`1,142,817`|`Restricted`
`funds`
`£`
`1,206`
`-`
`-`
`3,763`
`4,969`
`1,894`
`-`
`-`
`-`
`1,894`
`3,075`
`64,155`
`67,230`|`Total`
`funds`
`£`
`1,706`
`732,081`
`352`
`7,397`|
|---|---|---|
|||`741,536`|
|||`38,242`
`315,505`
`3,695`
`354,028`|
|||`711,470`|
|||`30,066`
`1,179,981`|
|||`1,210,047`|
```
continued...
```
```
Page 21
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Notes to the Financial Statements - continued for the Year Ended 31 December 2023`**
## **`15. GOING CONCERN`**
```
TheCharity'sfinancialstatementshavebeenpreparedon a goingconcernbasis.TheOrganization has
more than sufficient funds to continue operating for the foreseeable future.
```
## **`16. INTANGIBLE FIXED ASSETS`**
|**`INTANGIBLE FIXED ASSETS`**||
|---|---|
||`Website`|
||`£`|
|**`COST`**||
|`At 1 January 2023 and`||
|`31 December 2023`|**`30,370`**|
|**`AMORTISATION`**||
|`At 1 January 2023`|**`26,963`**|
|`Charge for year`|**`341`**|
|`At 31 December 2023`|**`27,304`**|
|**`NET BOOK VALUE`**||
|`At 31 December 2023`|**`3,066`**|
|`At 31 December 2022`|`3,407`|
## **`17. TANGIBLE FIXED ASSETS`**
|`Fixtures`
`and`
`Computer`
`fittings`
`equipment`
`£`
`£`
**`COST`**
`At 1 January 2023 and`
`31 December 2023`
**`3,528`**
**`4,459`**
**`DEPRECIATION`**
`At 1 January 2023 and`
`31 December 2023`
**`3,528`**
**`4,459`**
**`NET BOOK VALUE`**
`At 31 December 2023`
**`-`**
**`-`**
`At 31 December 2022`
`-`
`-`|`Totals`
`£`
**`7,987`**|
|---|---|
||**`7,987`**|
||**`-`**|
||`-`|
```
continued...
```
```
Page 22
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Notes to the Financial Statements - continued for the Year Ended 31 December 2023`**
## **`18. FIXED ASSET INVESTMENTS`**
```
The companyhas invested£1,248,000in a fund that in turn investsin listedsharesand gilts.The fund
is managed by fund managers. The shares and gilts are restricted to ethical assets.
```
## **`19. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**
|`Trade debtors`
`Prepayments and accrued income`
**`CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**
`VAT`
`Other creditors`
`Accruals and deferred income`
`Accrued expenses`
**`ANALYSIS OF NET ASSETS BETWEEN FUNDS`**
`Unrestricted`
`fund`
`£`
`Fixed assets`
**`3,066`**
`Investments`
**`-`**
`Current assets`
**`1,004,026`**
`Current liabilities`
**`(63,629)`**
**`943,463`**|`Restricted`
`funds`
`£`
**`-`**
**`1,248,000`**
**`67,723`**
**`-`**
**`1,315,723`**|**`2023`**
**`£`**
**`175`**
**`99,831`**
**`100,006`**
**`2023`**
**`£`**
**`3,550`**
**`20,440`**
**`31,429`**
**`8,210`**
**`63,629`**
**`2023`**
**`Total`**
**`funds`**
`£`
**`3,066`**
**`1,248,000`**
**`1,071,749`**
**`(63,629)`**
**`2,259,186`**|`2022`
`£`
`26,331`
`18,206`
`44,537`
`2022`
`£`
`8,265`
`281`
`16,985`
`4,300`
`29,831`
`2022`
`Total`
`funds`
`£`
`3,407`
`-`
`1,236,471`
`(29,831)`
`1,210,047`|
|---|---|---|---|
## **`20. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**
## **`21. ANALYSIS OF NET ASSETS BETWEEN FUNDS`**
```
continued...
```
```
Page 23
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Notes to the Financial Statements - continued for the Year Ended 31 December 2023`**
## **`22. MOVEMENT IN FUNDS`**
|`At 1/1/23`
`£`
**`Unrestricted funds`**
`General fund`
**`1,142,817`**
**`Restricted funds`**
`Cairns Campbell Connolly Prize Fund`
**`1,500`**
`Hugh Cairns Memorial Fund`
**`61,967`**
`The British Neurological Trainee`
`Research Collaborative`
**`3,763`**
`Global Neurosurgery`
**`-`**
**`67,230`**
**`TOTAL FUNDS`**
**`1,210,047`**
`Net movement in funds, included in the above are as follows:`
`Incoming`
`resources`
`£`
**`Unrestricted funds`**
`General fund`
**`713,430`**
**`Restricted funds`**
`Hugh Cairns Memorial Fund`
**`1,493`**
`Global Neurosurgery`
**`1,250,000`**
**`1,251,493`**
**`TOTAL FUNDS`**
**`1,964,923`**|`Net`
`movement`
`in funds`
`£`
**`(199,354)`**
**`-`**
**`493`**
**`-`**
**`1,248,000`**
**`1,248,493`**
**`1,049,139`**
`Resources`
`expended`
`£`
**`(912,784)`**
**`(1,000)`**
**`(2,000)`**
**`(3,000)`**
**`(915,784)`**|`At`
`31/12/23`
`£`
**`943,463`**
**`1,500`**
**`62,460`**
**`3,763`**
**`1,248,000`**
**`1,315,723`**
**`2,259,186`**
`Movement`
`in funds`
`£`
**`(199,354)`**
**`493`**
**`1,248,000`**
**`1,248,493`**
**`1,049,139`**|
|---|---|---|
```
continued...
```
```
Page 24
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Notes to the Financial Statements - continued for the Year Ended 31 December 2023`**
## **`22. MOVEMENT IN FUNDS - continued`**
## **`Comparatives for movement in funds`**
|**`Unrestricted funds`**
`General fund`
**`Restricted funds`**
`Cairns Campbell Connolly Prize Fund`
`Hugh Cairns Memorial Fund`
`The British Neurological Trainee`
`Research Collaborative`
**`TOTAL FUNDS`**
`Comparative net movement in funds, included in the above`
**`Unrestricted funds`**
`General fund`
**`Restricted funds`**
`Cairns Campbell Connolly Prize Fund`
`Hugh Cairns Memorial Fund`
`The British Neurological Trainee`
`Research Collaborative`
**`TOTAL FUNDS`**|`At 1/1/22`
`£`
`1,115,826`
`2,500`
`61,655`
`-`
`64,155`
`1,179,981`
`are as follows:`
`Incoming`
`resources`
`£`
`736,567`
`-`
`1,206`
`3,763`
`4,969`
`741,536`|`Net`
`movement`
`in funds`
`£`
`26,991`
`(1,000)`
`312`
`3,763`
`3,075`
`30,066`
`Resources`
`expended`
`£`
`(709,576)`
`(1,000)`
`(894)`
`-`
`(1,894)`
`(711,470)`|`At`
`31/12/22`
`£`
`1,142,817`
`1,500`
`61,967`
`3,763`
`67,230`
`1,210,047`
`Movement`
`in funds`
`£`
`26,991`
`(1,000)`
`312`
`3,763`
`3,075`
`30,066`|
|---|---|---|---|
||`ar`
`r`|||
```
continued...
```
```
Page 25
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Notes to the Financial Statements - continued for the Year Ended 31 December 2023`**
## **`22. MOVEMENT IN FUNDS - continued`**
```
A current year 12 months and prior year 12 months combined position is as follows:
```
|**`Unrestricted funds`**
`General fund`
**`Restricted funds`**
`Cairns Campbell Connolly Prize Fund`
`Hugh Cairns Memorial Fund`
`The British Neurological Trainee`
`Research Collaborative`
`Global Neurosurgery`
**`TOTAL FUNDS`**|`At 1/1/22`
`£`
`1,115,826`
`2,500`
`61,655`
`-`
`-`
`64,155`
`1,179,981`|`Net`
`movement`
`in funds`
`£`
`(172,363)`
`(1,000)`
`805`
`3,763`
`1,248,000`
`1,251,568`
`1,079,205`|`At`
`31/12/23`
`£`
`943,463`
`1,500`
`62,460`
`3,763`
`1,248,000`|
|---|---|---|---|
||||`1,315,723`|
||||`2,259,186`|
```
A currentyear12 monthsand prioryear12 monthscombinednet movementin funds,includedin the
above are as follows:
```
|**`Unrestricted funds`**
`General fund`
**`Restricted funds`**
`Cairns Campbell Connolly Prize Fund`
`Hugh Cairns Memorial Fund`
`The British Neurological Trainee`
`Research Collaborative`
`Global Neurosurgery`
**`TOTAL FUNDS`**|`Incoming`
`resources`
`£`
`1,449,997`
`-`
`2,699`
`3,763`
`1,250,000`
`1,256,462`
`2,706,459`|`Resources`
`expended`
`£`
`(1,622,360 )`
`(1,000)`
`(1,894)`
`-`
`(2,000)`
`(4,894)`
`(1,627,254 )`|`Movement`
`in funds`
`£`
`(172,363)`
`(1,000)`
`805`
`3,763`
`1,248,000`
`1,251,568`
`1,079,205`|
|---|---|---|---|
```
continued...
```
```
Page 26
```
Docusign Envelope ID: FD9C73C1-B96C-4C20-8992-308FE6EA636F
## **`THE SOCIETY OF BRITISH NEUROLOGICAL SURGEONS`**
## **`Notes to the Financial Statements - continued`**
## **`for the Year Ended 31 December 2023`**
## **`23. RELATED PARTY DISCLOSURES`**
```
There were no related party transactions for the year ended 31 December 2023.
```
## **`24. AUDIT COSTS`**
```
Audit costs in the year were £3,000 (2022 - nil)
```
```
Page 27
```